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Editorial on the Research Topic
Status Go for Preclinical Imaging
This special Research Topic includes a collection of reviews and original articles on preclinical
imaging. Preclinical imaging encompasses the use of imaging methods to study animal models,
tissue samples, and other unique specimens, such as eggs (in ovo). Preclinical imaging is driven
by advances in medical physics and instrumentation as well as by active research in biology
and medicine. Given the multi-disciplinary nature of preclinical imaging, some articles from this
collection appear in the journal Frontiers in Physics whereas others appear in the journal Frontiers
in Physiology.
Over time, preclinical imaging has evolved from a technique perceived to be niche and of
limited value to an established workhorse inmedical research, supporting drug discovery programs,
mechanistic studies focused on understanding (patho-)physiology and disease development as
well as progression, and aiding the development of paradigms for clinical imaging. Preclinical
imaging also encompasses scales of different orders of magnitude, from molecular/microscopic
to structural/macroscopic as well as organismic scale, thus providing not only superb anatomical
detail but also excellent quantitative functional information. Despite the tremendous and ever-
expanding role of preclinical imaging in medical research, its full potential can only be delivered
if preclinical researchers apply the same amount of effort and rigor to their preclinical protocols
as is used in clinical settings. This means that thoughtful study planning and use of established
standardized protocols, accompanied by careful handling of the subjects (e.g., animals, eggs,
or tissue samples) is of paramount importance to generate preclinical imaging datasets with
translational value. Furthermore, there is a need to implement robust image analysis approaches,
including reliable and reproducible methods to obtain quantitative data. Finally, state-of-the-art
statistical testing and controlling must be applied.
In the present Research Topic, 13 articles are divided into 6 reviews, 1 mini-review, 4
original research articles, 1 perspective, and 1 brief research report, covering some of the latest
research activities on diverse topics including microscopy, positron emission tomography (PET)
quantification, single photon emission computed tomography (SPECT) for neuroimaging, small
animal magnetic resonance imaging (MRI), ultrasound, in ovo imaging, in vivo cell tracking using
multiple imaging methods and correlated multimodal imaging (CMI).
The review article by Walter et al. provides a comprehensive overview of the challenges of CMI,
where information from the same specimen with two or more modalities is combined to create a
composite view of the sample. In this review paper, the different imaging techniques available for
CMI, including correlated light microscopy, electron microscopy, and biological hybrid imaging,
are described alongside the advantages and disadvantages of each modality.
Kuntner et al. Editorial: Preclinical Imaging
In this Frontiers special issue, five papers discuss the latest
research in nuclear imaging techniques. The paper by He et al.
describes strategies for the extraction of an arterial or image-
derived input function for quantification of the adenosine type
1 receptors (A1) with PET. The impact of attenuation correction
on [18F]FDGPET imaging is described byWanek et al. using data
from phantom and rat studies. Oelschlegel and Goldschmidt’s
paper focuses on describing the use of cerebral blood flow
SPECT imaging to study brain-wide activation patterns in
awake rodents. Dual tracer PET/SPECT studies are reported
by Blower et al. using phantoms to investigate the cross-
contamination of PET signal on SPECT measurements and vice-
versa. Finally, a perspective article by Jones et al. provides an
outlook at the possibilities of how preclinical imaging might be
instrumental to deliver the full potential of the clinical total-body
PET technology.
Traditionally, hybrid radionuclide imaging has been used
to study the physiology and pathophysiology in humans and
rodents. However, it can also be used to examine tumoral
uptake of radiotracers together with anatomical information
in the Hen’s Egg Test Chorioallantoic-Membrane (HET-
CAM) model by so-called in ovo imaging (Winter et al.).
This is an emerging new application for preclinical imaging.
Another more routine application of preclinical imaging
involves the use of imaging technology to track cells in
vivo and consequently help with the development of novel
cancer immunotherapies. Imaging methods used to track
cells are applied as summarized in the review by Iafrate
and Fruhwirth.
This special issue on preclinical imaging also covers the utility
of preclinical MRI as a promising diagnostic tool to monitor
disease progression and response to therapy in preclinical
models. Technical aspects of in vivo small animal cardiovascular
MRI are summarized in the review by Li et al. whereas Anderson
et al. describe the development of MR diffusion imaging
protocols for structural connectomics analysis in mouse models
of human disease.
Finally, the Research Topic is further complemented by
a review on preclinical ultrasound imaging techniques and
applications (Moran and Thomson) and a mini-review on
recent technological and methodological advances in the field of
multiphoton microscopy (Pozzi et al.).
The Research Topic editors greatly appreciate the amount
of work from contributors, reviewers, and Frontiers staff. We
believe that the articles published in this Research Topic provide
further evidence that preclinical imaging is an invaluable tool in
medical and biological research and will continue to supply the
field with new critical knowledge on the causes, consequences,
and treatment options of multiple diseases. This is a moment
when the preclinical imaging community needs to go further,
continuing to push the limits of this tool.
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